To further verify the effect of Sch B on HCC, we conducted an in vivo experiment and showed that Sch B inhibited the growth of HCC tumors, and the expression of FN1 in the Sch B-treated group was lower than that in the control group. Here, FN1 is linked to hepatocellular carcinoma.